drugset / Trial / NCT02368652

A Study to Evaluate the Efficacy and Safety of Amlodipine Besylate and Candesartan Cilexetil in Essential Hypertension Patient Who Are Not Adequately Controlled With Candesartan Cilexetil Monotherapy

NCT02368652

Phase 3 Completed 181 enrolled HK inno.N Corporation
RandomizedParallel-groupQuadruple-blindTreatment

Summary

Compare the safety and efficacy of amlodipine besylate and candesartan cilexetil combination therapy on patients of essential hypertension who are not properly controlled by candesartan cilexetil monotherapy.

Timeline

Start
2014-12
Primary completion
2015-11
Completion
2015-11

Drugs

EvaluationDrugModalityDoseRoute
Subject Amlodipine Other / unclassified 10 mg Oral
Subject Candesartan cilexetil Unknown 16 mg Oral